Skip to main content
. 2020 Apr 14;11(15):1373–1387. doi: 10.18632/oncotarget.27550

Figure 2. Treatment with low dose Rapatar reduces the number of proliferating cells in the prostate of PCa-prone psPten–/– mice.

Figure 2

Representative anterior prostate lobe (AP), ventral prostate lobe (VP), and lateral prostate lobe (LP) sections stained with anti-Ki67 are shown for (A) Pten-positive mice, (B) psPten–/– mice treated with vehicle, and (C) psPten–/– mice treated with 5 mg/kg Rapatar. Red – Ki67, Blue-DAPI; White arrows indicate Ki67-positive nuclei.